|
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway |
|
|
|
Titel: |
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway |
Auteur: |
Giurdanella, Giovanni Anfuso, Carmelina Daniela Olivieri, Melania Lupo, Gabriella Caporarello, Nunzia Eandi, Chiara M. Drago, Filippo Bucolo, Claudio Salomone, Salvatore |
Verschenen in: |
Biochemical pharmacology |
Paginering: |
Jaargang 96 (2015) nr. 3 pagina's 10 p. |
Jaar: |
2015 |
Inhoud: |
|
Uitgever: |
Elsevier Inc. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|